SCHEMBL5710409

SCHEMBL5710409

O[C@@H]1CCN(c2cccc(F)c2)C1

nearest known ligand 0.61

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
BPTF Q12830 1/20 0.61
AR P10275 1/20 0.48
HSD11B1 P28845 3/20 0.47
MLYCD O95822 1/20 0.43
NOTUM Q6P988 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2334802 1.00 BPTF (0.61) BPTFARHSD11B1MLYCDNOTUM
SCHEMBL1349684 0.80 BPTF (0.66) BPTFMLYCDNOTUM
SCHEMBL30252765 0.80 AR (0.48) BPTFARNOTUM
SCHEMBL28996058 0.80 AR (0.48) BPTFARNOTUM
SCHEMBL31441994 0.80 AR (0.48) BPTFARNOTUM
SCHEMBL6467831 0.80 AR (0.48) BPTFARNOTUM
SCHEMBL31442179 0.80 AR (0.48) BPTFARNOTUM
SCHEMBL365887 0.80 AR (0.48) BPTFARNOTUM
SCHEMBL22657734 0.80 BPTF (0.61) BPTFMLYCDNOTUM
SCHEMBL27330017 0.80 NOTUM (0.64) ARNOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113493628-A Quantum dot ink and preparation method of quantum dot film TCL科技集团股份有限公司 2021-10-12 CN claimed
CN-113122053-A Quantum dot ink and preparation method of quantum dot film TCL集团股份有限公司 2021-07-16 CN claimed
CN-113493628-A Quantum dot ink and preparation method of quantum dot film TCL科技集团股份有限公司 2021-10-12 CN disclosed
CN-113122053-A Quantum dot ink and preparation method of quantum dot film TCL集团股份有限公司 2021-07-16 CN disclosed
EP-1707206-A1 Piperazine derivates for the inhibition of beta-secretase, cathepsin D, plasmepsin ll and HIV protease and for the treatment of malaria, Alzeheimer and AIDS Speedel Experimenta AG (CH) 2006-10-04 EP disclosed
WO-2005037803-A1 ORGANIC COMPOUNDS SPEEDEL EXPERIMENTA AG (CH) 2005-04-28 WO disclosed